Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD

This was a one-year, Phase III randomized, double-blind, parallel-group active-control study investigating the long-term safety and tolerability of a twice-daily aclidinium 400 μg/formoterol 12 μg versus formoterol 12 μg.

Source: Respiratory Medicine CME - May 6, 2016 Category: Respiratory Medicine Authors: James F. Donohue, Weily Soong, Xiao Wu, Pomy Shrestha, Alejhandra Lei Source Type: research